Future epidemiological and economic impacts of universal influenza vaccines

The efficacy of influenza vaccines, currently at 44%, is limited by the rapid antigenic evolution of the virus and a manufacturing process that can lead to vaccine mismatch. The National Institute of Allergy and Infectious Diseases (NIAID) recently identified the development of a universal influenza...

Descripción completa

Detalles Bibliográficos
Autores principales: Sah, Pratha, Alfaro-Murillo, Jorge A., Fitzpatrick, Meagan C., Neuzil, Kathleen M., Meyers, Lauren A., Singer, Burton H., Galvani, Alison P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2019
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789917/
https://www.ncbi.nlm.nih.gov/pubmed/31548402
http://dx.doi.org/10.1073/pnas.1909613116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789917/
https://www.ncbi.nlm.nih.gov/pubmed/31548402
http://dx.doi.org/10.1073/pnas.1909613116

Ejemplares similares